Sebastian M Toescu1,2, Kristian Aquilina3. 1. Developmental Imaging and Biophysics Section, UCL-GOS Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK. 2. Department of Neurosurgery, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK. 3. Department of Neurosurgery, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK. Kristian.aquilina@gosh.nhs.uk.
Abstract
PURPOSE OF REVIEW: This review discusses the evidence base behind current and emerging strategies of management of intracranial and spinal ependymomas in children, with a particular focus on aspects of surgical techniques, challenges and complications. RECENT FINDINGS: The cornerstone of management remains maximal safe resective surgery, which has repeatedly been shown to correlate with improved survival. This is followed by focal conformal radiotherapy, although good results using proton beam therapy, with the potential for diminished side effects, are emerging. The role of chemotherapy remains largely unproven for paediatric ependymoma. Despite optimal management strategies, many children with ependymoma suffer from tumour recurrence. The standard of care for paediatric ependymoma comprises surgery and radiotherapy. Results of ongoing clinical trials will help shape its management in order to leverage our increasingly sophisticated understanding of the genetic drivers behind these tumours into survival benefit for this challenging group of patients.
PURPOSE OF REVIEW: This review discusses the evidence base behind current and emerging strategies of management of intracranial and spinal ependymomas in children, with a particular focus on aspects of surgical techniques, challenges and complications. RECENT FINDINGS: The cornerstone of management remains maximal safe resective surgery, which has repeatedly been shown to correlate with improved survival. This is followed by focal conformal radiotherapy, although good results using proton beam therapy, with the potential for diminished side effects, are emerging. The role of chemotherapy remains largely unproven for paediatric ependymoma. Despite optimal management strategies, many children with ependymoma suffer from tumour recurrence. The standard of care for paediatric ependymoma comprises surgery and radiotherapy. Results of ongoing clinical trials will help shape its management in order to leverage our increasingly sophisticated understanding of the genetic drivers behind these tumours into survival benefit for this challenging group of patients.
Entities:
Keywords:
Cerebellopontine angle; Chemotherapy; Ependymoma; Paediatric; Radiotherapy; Surgery
Authors: J Grill; M C Le Deley; D Gambarelli; M A Raquin; D Couanet; A Pierre-Kahn; J L Habrand; F Doz; D Frappaz; J C Gentet; C Edan; P Chastagner; C Kalifa Journal: J Clin Oncol Date: 2001-03-01 Impact factor: 44.544
Authors: C Ebert; M von Haken; B Meyer-Puttlitz; O D Wiestler; G Reifenberger; T Pietsch; A von Deimling Journal: Am J Pathol Date: 1999-08 Impact factor: 4.307
Authors: Arnold C Paulino; B-Chen Wen; John M Buatti; David H Hussey; Weining K Zhen; Nina A Mayr; Arnold H Menezes Journal: Am J Clin Oncol Date: 2002-04 Impact factor: 2.339
Authors: Thomas E Merchant; Raymond K Mulhern; Matthew J Krasin; Larry E Kun; Tani Williams; Chenghong Li; Xiaoping Xiong; Raja B Khan; Robert H Lustig; Frederick A Boop; Robert A Sanford Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: Carlos A Bagley; Karl F Kothbauer; Sean Wilson; Markus J Bookland; Fred J Epstein; George I Jallo Journal: J Neurosurg Date: 2007-04 Impact factor: 5.115
Authors: H Stacy Nicholson; Cynthia S Kretschmar; Mark Krailo; Mark Bernstein; Richard Kadota; Daniel Fort; Henry Friedman; Michael B Harris; Nicole Tedeschi-Blok; Claire Mazewski; Judith Sato; Gregory H Reaman Journal: Cancer Date: 2007-10-01 Impact factor: 6.860
Authors: Hui-Kuo G Shu; Walter F Sall; Amit Maity; Zelig A Tochner; Anna J Janss; Jean B Belasco; Lucy B Rorke-Adams; Peter C Phillips; Leslie N Sutton; Michael J Fisher Journal: Cancer Date: 2007-07-15 Impact factor: 6.860
Authors: Richard G Grundy; Sophie A Wilne; Claire L Weston; Kath Robinson; Linda S Lashford; James Ironside; Tim Cox; W Kling Chong; Richard H A Campbell; Cliff C Bailey; Rao Gattamaneni; Sue Picton; Nicky Thorpe; Conor Mallucci; Martin W English; Jonathan A G Punt; David A Walker; David W Ellison; David Machin Journal: Lancet Oncol Date: 2007-08 Impact factor: 41.316
Authors: Aladine A Elsamadicy; Andrew B Koo; Wyatt B David; Victor Lee; Cheryl K Zogg; Adam J Kundishora; Christopher S Hong; Tyrone DeSpenza; Benjamin C Reeves; Kristopher T Kahle; Michael DiLuna Journal: Neurooncol Adv Date: 2020-02-21